BayBridge Capital Group »

Entrada Therapeutics shares owned by BayBridge Capital Group

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by BayBridge Capital Group from 13F filings

Historical chart of BayBridge Capital Group investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by BayBridge Capital Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by BayBridge Capital Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $494k 29k 17.29
2024-09-30 $464k 29k 15.98

More positions owned by BayBridge Capital Group

Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Series Trust Bloomberg Sht Te (SJNK)
NVIDIA Corporation (NVDA)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Amazon (AMZN)
Broadcom (AVGO)
Microsoft Corporation (MSFT)

View all positions for BayBridge Capital Group

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
MPM Asset Management
5AM Venture Management
BlackRock
Vanguard Group
Wellington Management Company
Millennium Management
StepStone
Geode Capital Management
Renaissance Technologies
TCG Crossover Management
State Street Corporation
Dimensional Fund Advisors
Royce & Associates
Citadel Advisors

View all funds holding Entrada Therapeutics